One of the most significant discoveries enabled by advanced metabolomic analysis was the role of plasmalogens, a class of phospholipids essential to human health.
These molecules were identified by Dr. Dayan Goodenowe during clinical research involving cognitive impairment and Alzheimer’s disease. Using non-targeted metabolomics, he observed consistent depletion of unusual phospholipids in affected individuals. Their molecular structure differed slightly from typical phospholipids, containing seven oxygen atoms instead of eight.
But these compounds were not new. Plasmalogens were first discovered nearly a century ago. What had been overlooked was their significance.
Plasmalogens Are Abundant in Key Organs
Plasmalogens are abundant in the body, particularly in organs with high metabolic and structural demands, such as the brain, heart, lungs, kidneys, and eyes.
Historical postmortem studies had shown reduced plasmalogen levels in diseased brains, but these findings were largely dismissed. The prevailing belief was that the brain was biochemically isolated and that plasmalogen depletion was merely a consequence of disease and oxidative stress.
Advanced metabolomic data challenged that assumption. Depletion was observable in the blood, and further research revealed mechanisms linking plasmalogen loss to neurodegenerative processes. Low levels were not simply an outcome of disease; they were part of the underlying biology.
Expanding Research Into Plasmalogen Function and Aging
Once their importance became clear, plasmalogens became the focus of expanded clinical and laboratory research. Their role in membrane integrity, cellular signaling, and metabolic resilience placed them at the center of both physical and cognitive function.
As research progressed, it also became evident that plasmalogen depletion is a defining feature of aging. Declining levels correlate with loss of biological reserve across multiple systems.
To address this, Dr. Goodenowe developed numerous plasmalogen precursors that could selectively restore certain types of these natural plasmalogen molecules. These biochemical precursors are 100% natural and enter directly into the body’s natural biochemical pathways.
Beyond a Single Molecule
The significance of plasmalogens extends beyond any one condition. Their discovery highlighted the broader importance of foundational biochemical systems, those that quietly support structure, energy production, and resilience.
This understanding expanded the investigation into related systems, including mitochondrial function and lipid regulation. Together, these insights reinforced a central principle: health must be measured and supported at the biochemical level.
A Shift in Perspective
Rather than focusing exclusively on disease endpoints, this work supports an alternative framework, centred on maintaining reserve capacity and biological stability over time.
By identifying early biochemical changes and addressing them systematically, it becomes possible to move toward sustained health rather than reactive intervention.
Plasmalogens represent one piece of that larger picture, but they illustrate how much can be revealed when biology is measured comprehensively and without assumptions.
Plasmalogens were identified through a broader framework for measuring early biochemical change.
Read: How Blood Biomarkers Reveal Early Signs of Health Decline